drugset / Trial / NCT05491759

A Study to Determine Optimal Absorption of Single Dose Omega-3

NCT05491759 ↗

Phase 4 Completed 22 enrolled RDC Clinical Pty Ltd
RandomizedCrossoverDouble-blindOther

Summary

This is a randomised three-way cross over study comparing the optimal absorption of a single dose of fish oil using 3 different forms to one another on increasing blood concentrations of fatty acids in 24 healthy adult participants aged 19 years and over.

Timeline

Start
2022-08-04
Primary completion
2022-09-28
Completion
2022-09-28

Drugs

EvaluationDrugModalityDoseRoute
Subject AquaCelle Fish Oil Ethyl Ester Unknown 0.28 g Oral
Subject AquaCelle Fish Oil Ethyl Ester Unknown 1.6 g Oral
Subject AquaCelle Fish Oil Triglyceride Unknown 0.4 g Oral
Subject AquaCelle Fish Oil Triglyceride Unknown 1.6 g Oral
Subject Standard Fish Oil Triglyceride Unknown 1.6 g Oral

Indications

No indication recorded.